Recent research shows that women who start the most common type of hormone therapy — estrogen plus progestin — soon after menopause have a significantly higher risk of breast cancer than those who take the hormones later or not at all. James Simon, M.D., clinical professor of Obstetrics and Gynecology in the School of Medicine and Health Sciences, says estrogen promotes the growth of almost everything, including undetectable tumors in the breasts.
Considering Hormone Replacement Therapy?
Latest News
The GW Cancer Center announced the appointment of Katherine Chiappinelli, PhD, as Deputy Director for Basic Sciences. In this role, Chiappinelli will work with Edward Seto, PhD, associate center director for basic science at the GW Cancer Center, and the King Fahd Professor of Cancer Biology, to…
Paige McDonald, EdD ’12, MA, vice chair and associate professor in the Department of Clinical Research and Leadership (CRL), has been selected to serve as Interim Chair of the department. A leader in curriculum and educational innovation, McDonald has been a member of the GW faculty since 2008. An…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) welcomed the members of the MD Program Class of 2030 into the medical profession Aug. 29, during the school’s 28th Annual White Coat and Honor Code Ceremony at Lisner Auditorium.
